The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.05
Bid: 48.95
Ask: 49.30
Change: 0.20 (0.41%)
Spread: 0.35 (0.715%)
Open: 49.90
High: 49.90
Low: 48.60
Prev. Close: 48.85
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WaveOptics completes £20.0m funding round

11 Dec 2018 07:00

RNS Number : 0390K
IP Group PLC
11 December 2018
 

FOR RELEASE ON

11 December 2018

 

IP Group plc - Portfolio company WaveOptics completes £20.0m funding round

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, is pleased to note that portfolio company WaveOptics ("WaveOptics" or "the Company"), the world leading designer and manufacturer of diffractive waveguides for use in Augmented Reality (AR) wearables, has completed a £20.0m fundraising.

 

The round was led by Octopus Ventures and supported by existing shareholders including IP Group, Robert Bosch Venture Capital (RBVC) and Gobi Partners as well as new investors Goertek and Optimas Capital Partners.

 

Goertek is a global leader in the design and manufacturing of high-tech consumer electronics. Goertek's investment is a significant development for the business and follows the announcement on 28 November 2018 that WaveOptics and Goertek have agreed an exclusive manufacturing partnership that will enable the global mass production of waveguides.

 

Following completion of the first tranche of the financing round, IP Group's direct undiluted beneficial stake of 19.9% in WaveOptics is valued at £15.2 million, representing a direct unrealised fair value gain to IP Group of £7.6 million. IP Group committed £3.7 million to the fundraising.

 

Robert Bahns, Partner of Technology at IP Group plc, said: "WaveOptics is making excellent progress and we believe the Company has the best solution both from a commercial and technical standpoint for providing the key component in AR devices. This is being demonstrated by the level of engagement with its key customers."

 

The funds will be used to scale up WaveOptics' operations on a national and international basis. WaveOptics is building a large volume manufacturing supply chain to meet customer demand from the Asian and US markets. The Company is also investing in its overseas infrastructure having recently opened offices in Los Angeles and Taipei and plans to open a new office in Beijing in 2019.

 

WaveOptics' funding round represents the largest AR hardware fundraise in Europe in 2018. The Company is in advanced discussions with potential new shareholders and strategic partners about a second stage investment.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive OfficerGreg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

Andrew Wilson

+44 (0) 7810 636995

Martha Walsh

+44 (0) 7876 245962

Tom Gillingham

+44 (0) 7741 659021

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

Group holdings in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFFWESSFASELE
Date   Source Headline
26th Apr 20245:29 pmRNSTransaction in Own Shares
26th Apr 20243:36 pmRNSEmployee Share Schemes; Director/PDMR shareholding
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20246:05 pmRNSNotice of AGM, Annual Report
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20245:48 pmRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20245:56 pmRNSTransaction in Own Shares
9th Apr 20245:31 pmRNSTransaction in Own Shares
8th Apr 20245:32 pmRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20245:27 pmRNSTransaction in Own Shares
3rd Apr 20245:37 pmRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20245:30 pmRNSTransaction in Own Shares
25th Mar 20246:03 pmRNSTransaction in Own Shares
25th Mar 20248:54 amRNSDirector Declaration
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:56 pmRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20245:03 pmRNSDirector Declaration
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNS2023 Annual Results
12th Mar 20245:24 pmRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSCorrection - Holding(s) in Company
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20242:35 pmRNSHolding(s) in Company
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20245:02 pmRNSTransaction in Own Shares
4th Mar 20245:34 pmRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20249:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.